Appleton Partners Inc Gilead Sciences, Inc. Transaction History

Appleton Partners Inc

$1.36 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$77.31 - $88.08 $232,703 - $265,120	3,010 New	3,010 $250,000
Q3 2022 Oct 27, 2022	SELL	$59.54 - $68.01 $55,193 - $63,045	-927 Reduced 22.06%	3,275 $202,000
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $186,608 - $210,177	-3,233 Reduced 43.48%	4,202 $260,000
Q1 2022 Apr 05, 2022	SELL	$57.92 - $72.58 $111,380 - $139,571	-1,923 Reduced 20.55%	7,435 $442,000
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $19,853 - $22,533	306 Added 3.38%	9,358 $679,000
Q2 2021 Jul 07, 2021	SELL	$63.47 - $69.35 $23,547 - $25,728	-371 Reduced 3.94%	9,052 $623,000
Q1 2021 Apr 19, 2021	SELL	$60.0 - $68.46 $9,420 - $10,748	-157 Reduced 1.64%	9,423 $609,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $53,251 - $60,677	-940 Reduced 8.94%	9,580 $558,000
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $201,887 - $253,838	3,251 Added 44.72%	10,520 $665,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $79,429 - $92,232	1,098 Added 17.79%	7,269 $559,000
Q1 2020 May 04, 2020	BUY	$62.63 - $80.22 $386,489 - $495,037	6,171 New	6,171 $461,000
Q4 2019 Jan 13, 2020	SELL	$61.62 - $67.78 $490,495 - $539,528	-7,960 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $46,882 - $51,750	-750 Reduced 8.61%	7,960 $505,000
Q2 2019 Jul 25, 2019	SELL	$61.87 - $69.38 $43,927 - $49,259	-710 Reduced 7.54%	8,710 $588,000
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $280,071 - $313,753	-4,479 Reduced 32.23%	9,420 $612,000
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $72,103 - $94,089	-1,191 Reduced 7.89%	13,899 $869,000
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $209,777 - $232,261	-2,943 Reduced 16.32%	15,090 $1.17 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $173,229 - $202,065	-2,670 Reduced 12.9%	18,033 $1.28 Million
Q1 2018 Apr 11, 2018	SELL	$72.84 - $88.8 $137,667 - $167,832	-1,890 Reduced 8.37%	20,703 $1.56 Million
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $39,417 - $46,270	-554 Reduced 2.39%	22,593 $1.62 Million
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $1.67 Million - $1.98 Million	23,147	23,147 $1.88 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Account